fda warning bpc 157 safety status not approved Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing Peptides: What they are, potential
Description
The gap: human evidence This section is the one most worth dwelling on
References inline (PubMed / NEJM citations as available)
These are inferred from the ratio, not confirmed vial contents , and they sum to ~2.36 mg versus the 2.33 mg stated (rounding)
GLP-1 agonists can drive significant weight loss, but without adequate dietary protein and resistance training, you will lose vital lean muscle massa serious longevity liability
